Ingredia S.A.   Report issue

For profit Phase 1
Founded: Arras France (1991)
Status: No NME R&D (1991)

Organization Overview

First Clinical Trial
2018
NCT04282096
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2022

Timeline

NOW
  • Now

Alternative names

Ingredia S.A.

Active Ingredients

Drugs in Phase 1 Trials (1)

maltodextrin (3 trials)

Drugs in Other Trials (5)

casein (2 trials)

hydrolyzed casein (1 trial)

milk protein (2 trials)

pea protein (1 trial)

turmeric (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Prediabetic State (Phase 1)

Overview

  • Highest Phase: Phase 1
  • # of Trials: 7
  • # of Trial APIs: 6